Health2047 an innovation firm based in Silicon Valley and backed up by AMA is now team up with leaders in technology and healthcare to develop and commercialize solutions to improve the healthcare industry. Health2047 is facilitating data liquidity, improving chronic care, harnessing emerging technologies to serve the patient-physician interface and optimizing the value of healthcare. 

Focusing on these core areas, health2047 has been able to launch Akiri, a data liquidity solution, and First Mile Care, a platform providing personalized support and resources to help reverse chronic diseases such as pre-diabetes.

The founding partner of health2047 is none other than AMA, together they focusing on bringing about innovation centered on the doctor and the patient. Health2047 is an independent firm and has the ability to focus on leveraging capital to create solutions to improve the healthcare sector.

Health2047 is focusing on problems that need to be solved right now. It is trying to create solutions for data liquidity with the help of the technology sector. Akiri switch is the first spun out the business of health2047 that aims to improve the data liquidity by providing a secure data transfer protocol.

Health2047 is developing solutions that involve combining deep expertise, immense scale, and powerful collaboration. The expertise and scale come from leveraging the massive assets like data and other assets. Participants work together to identify the problems of greatest priority, and it is further explored by health2047. The team members that define the potential solutions test the solutions and help bring solutions to the market.

Akiri switches the first business firm by health2047, which focuses on data operability and portability by building trusted networks for health data. Akiri Switch, the software-defined network, is used by global pharmaceutical company Celgene. Another separate business entity by health2047 is First Mile Care, a non-medical company focused on community approaches to chronic care management, particularly in diabetes prevention. The company has an ambitious plan to create a digitally connected network of diabetes-prevention coaches across the nation’s 42,000 ZIP codes.

The article explains health2047 and its separate entities Akiri switch and First Mile Care that is working to improve the healthcare system.

Douglass Given, MD, PhD 
Doug given is one of the experienced people who is serving as the board at Akiri. He is also a Managing Partner at Health2047. He has provided his services as Chief Executive from start to January 2018 at Health2047 Inc. before joining health2047 and Akiri, he was serving life sciences investor Bay City Doug as an Investment Partner and General Partner. He is a physician and medical scientist by background.  He has also served as a global corporate and operating executive at Lilly, Monsanto, Schering Plough, and Mallinckrodt and a serial entrepreneur. He has also led three public biotechnology and biopharmaceutical companies as CEO.
He is a Director at Health2047 Inc., board Chair at Akiri Inc. and Arrowhead Pharmaceuticals Inc., Managing Partner at G5 Partners LLC, and serves on the board at First Mile Care Inc. and Vivaldi Biosciences Inc. He is also serving the advisory boards at the University of Chicago Medicine, Johns Hopkins Bloomberg School of Public Health, Stanford Medicine, Stanford Institute for Economic Policy Research (SIEPR), and The Houston Methodist Research Institute.
Dr. James Madara 
Dr. James Madara is serving as the CEO of the American Medical Association (AMA). He is providing his services as a Director at Akiri. He is serving Akiri with the valuable experience he’s gained while addressing strategic, operational and financial challenges at both medical and biosciences organizations.
James is passionate about creating a healthcare system that delivers better outcomes for all. Before joining AMA, he has served the University of Chicago, as CEO of the medical center and dean of the Biological Sciences Division and Pritzker School of Medicine. He has also worked as Timmie Professor and chair of the department of pathology and laboratory medicine at Emory University, and professor of pathology at Harvard Medical School. 
Ray Bingham, PhD 
Ray has more 35 years of working experience with businesses in high tech, chemical engineering, and hospitality real estate development. He is the Co-Founder and Founding Partner of Canyon Bridge Capital Partners, Inc. before joining, health2047 he served as a Strategic Advisor of EPIC Ventures, where he led investment activities in the Communications and Electronics sector. He has also served as a director at including Oracle, Cypress Semiconductor, Freescale Semiconductor, and Onyx Software.
The article contains the details of the board of directors at Akiri switch. Akiri is the first spun out the business of health2047 that is dealing with data liquidity.